Soleno Therapeutics (SLNO) Change in Receivables: 2013-2017
Historic Change in Receivables for Soleno Therapeutics (SLNO) over the last 4 years, with Sep 2017 value amounting to -$3,000.
- Soleno Therapeutics' Change in Receivables fell 50.00% to -$3,000 in Q3 2017 from the same period last year, while for Sep 2017 it was -$25,790, marking a year-over-year decrease of 141.51%. This contributed to the annual value of -$22,790 for FY2016, which is 114.60% down from last year.
- Per Soleno Therapeutics' latest filing, its Change in Receivables stood at -$3,000 for Q3 2017, which was down 113.04% from $23,000 recorded in Q2 2017.
- Soleno Therapeutics' 5-year Change in Receivables high stood at $82,000 for Q3 2015, and its period low was -$150,000 during Q1 2014.
- For the 3-year period, Soleno Therapeutics' Change in Receivables averaged around $11,849, with its median value being $4,000 (2015).
- Per our database at Business Quant, Soleno Therapeutics' Change in Receivables slumped by 17,350.00% in 2014 and then spiked by 331.58% in 2015.
- Soleno Therapeutics' Change in Receivables (Quarterly) stood at $218 in 2013, then slumped by 17,350.00% to -$37,605 in 2014, then skyrocketed by 265.21% to $62,127 in 2015, then crashed by 136.68% to -$22,790 in 2016, then plummeted by 50.00% to -$3,000 in 2017.
- Its last three reported values are -$3,000 in Q3 2017, $23,000 for Q2 2017, and -$23,000 during Q1 2017.